FDA approves blood test method for colon cancer screening
The FDA approved Guardant Health's Shield blood test for colon cancer screening, making it likely to be covered by Medicare and private insurers. It is effective at detecting later-stage cancers but not early-stage polyps. A positive result requires follow-up with a colonoscopy. Doctors see potential for increased screening rates, but its impact on reducing mortality remains to be seen.
from World News Headlines, Latest International News, World Breaking News - Times of India https://ift.tt/QlbLDMO
from World News Headlines, Latest International News, World Breaking News - Times of India https://ift.tt/QlbLDMO
Comments
Post a Comment